Natera Inc.

01/22/2022 | Press release | Distributed by Public on 01/22/2022 13:45

Landmark CIRCULATE-Japan Study Shows Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer